Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies.

Diabetes Metab J · 2015 · PMC4641966 · PMID 26566494

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, the SAVOR-TIMI 53 trial revealed a completely unexpected HF signal with a highly significant 27% increase, which has not yet been explained [ 25 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.